Eunice Dai Clinical Oncology Society of Australia Annual Scientific Meeting 2018

Abstracts this author is presenting:

• The incidence and severity of breakthrough nausea and vomiting with palonosetron & dexamethasone requiring addition of NK1-receptor antagonists (NK1RA) in subsequent cycles in three highly or high-risk moderately emetogenic chemotherapy (HEC and high MEC) regimens — Poster Session 1